HAEMONETICS CORPORATION | 49,377 Euro | -0,305 -0,61 % | |
| WKN: 881782 ISIN: US4050241003 Ticker-Symbol: HAZ | Frankfurt | 10.02.12 | 15:38 Uhr |
Branche MedienAktienmarkt Sonstige |
|
| Zeit | Aktuelle Nachrichten | Leser | Medien | |
|---|---|---|---|---|
| 06.02. | Haemonetics to Present at Leerink Swann 2012 Global Healthcare Conference | 5 | PR Newswire | |
| BRAINTREE, Mass., Feb. 6, 2012 /PRNewswire/ --Haemonetics Corporation (NYSE: HAE) announced today that Chris Lindop, CFO and VP, Business Development, will present at the Leerink Swann... Mehr lesen zu: Haemonetics to Present at Leerink Swann 2012 Global Healthcare Conference | ||||
| 31.01. | Haemonetics Beats Estimates | - | Zacks | |
| 31.01. | Haemonetics Beats Analyst Estimates on EPS | - | Motley Fool | |
| 30.01. | Shorts Get Squeezed as Haemonetics Tops Earnings Estimates | - | Schaeffer's Research | |
| 30.01. | UPDATE 1-Haemonetics Q3 profit beats, backs FY outlook | - | Reuters.com | |
| 30.01. | Haemonetics Reports 8% Revenue Growth for Third Quarter of Fiscal 2012 and $0.86 Adjusted EPS; Announces Multi-Year Contract Extensions With Key Plasma Collection Customers; And Affirms Fiscal 2012 Guidance | 31 | PR Newswire | |
| BRAINTREE, Mass., Jan. 30, 2012 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) today reported third quarter 2012 GAAP net revenue of $191.2 million, up 8%, net income of $18.3 million, down 8%... Mehr lesen zu: Haemonetics Reports 8% Revenue Growth for Third Quarter of Fiscal 2012 and $0.86 Adjusted EPS; Announces Multi-Year Contract Extensions With Key Plasma Collection Customers; And Affirms Fiscal 2012 Guidance | ||||
| 13.01. | Haemonetics Sets Date for Third Quarter Fiscal Year 2012 Earnings Release: January 30, 2012 | 28 | PR Newswire | |
| BRAINTREE, Mass., Jan. 13, 2012 /PRNewswire/ --Haemonetics Corporation (NYSE:HAE) will announce its earnings for the third quarter of its 2012 fiscal year on January 30, 2012 in a pre-market... Mehr lesen zu: Haemonetics Sets Date for Third Quarter Fiscal Year 2012 Earnings Release: January 30, 2012 | ||||
| 03.01. | Haemonetics to Present at 30th Annual J.P. Morgan Health Care Conference | 6 | PR Newswire | |
| BRAINTREE, Mass., Jan. 3, 2012 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced today that Brian Concannon, President & CEO, will present at the J.P. Morgan 30th Annual Health... Mehr lesen zu: Haemonetics to Present at 30th Annual J.P. Morgan Health Care Conference | ||||
| 09.12. | Zacks Sell List Highlights: Foster Wheeler AG, ITT, Spectrum Brands Holdings and Haemonetics | 31 | PR Newswire | |
| CHICAGO, Dec. 9, 2011 /PRNewswire/ -- Zacks.com releases details on a group of stocks that are currently members of the exclusive Zacks #5 Rank List - Stocks to Sell Now. These stocks are currently... Mehr lesen zu: Zacks Sell List Highlights: Foster Wheeler AG, ITT, Spectrum Brands Holdings and Haemonetics | ||||
| 03.11. | HAEMONETICS CORP - 10-Q, Quarterly Report | 2 | SEC Filings | |
| 03.11. | Zacks Sell List Highlights: Gannett, Whirlpool, Hasbro and Haemonetics | 39 | PR Newswire | |
| CHICAGO, Nov. 3, 2011 /PRNewswire/ -- Zacks.com releases details on a group of stocks that are currently members of the exclusive Zacks #5 Rank List - Stocks to Sell Now. These stocks are currently... Mehr lesen zu: Zacks Sell List Highlights: Gannett, Whirlpool, Hasbro and Haemonetics | ||||
| 31.10. | Haemonetics verpasst Gewinnerwartungen und senkt Prognose | 71 | BörseGo | |
| Braintree (BoerseGo.de) - Haemonetics, ein Dienstleister im Bereich Blutkonserven und Blutplasma, hat den Umsatz im zweiten Quartal des Geschäftsjahres 2011/12 um 8 Prozent auf 179,4 Millionen US-Dollar... Mehr lesen zu: Haemonetics verpasst Gewinnerwartungen und senkt Prognose | ||||
| 31.10. | Haemonetics Reports 8% Revenue Growth for Second Quarter of Fiscal 2012, Adjusted Earnings Per Share of $0.72 and Updates Previously Provided Full Year Earnings Guidance | 6 | PR Newswire | |
| BRAINTREE, Mass., Oct. 31, 2011 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) today reported second quarter 2012 GAAP net revenues of $179.4 million, up 8%, net income of $13.9 million, down... Mehr lesen zu: Haemonetics Reports 8% Revenue Growth for Second Quarter of Fiscal 2012, Adjusted Earnings Per Share of $0.72 and Updates Previously Provided Full Year Earnings Guidance | ||||
| 12.10. | Haemonetics to Present at Stephens Inc. Fall Investment Conference | 5 | PR Newswire | |
| BRAINTREE, Mass., Oct. 12, 2011 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced today that Brian Concannon, President & CEO, will present at Stephens Inc. Fall Investor Conference in... Mehr lesen zu: Haemonetics to Present at Stephens Inc. Fall Investment Conference | ||||
| 30.09. | Haemonetics Sets Date for Second Quarter Fiscal Year 2012 Earnings Release: October 31, 2011 | 20 | PR Newswire | |
| BRAINTREE, Mass., Sept. 30, 2011 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) will announce its earnings for the second quarter of its 2012 fiscal year on October 31, 2011 in a pre-market press... Mehr lesen zu: Haemonetics Sets Date for Second Quarter Fiscal Year 2012 Earnings Release: October 31, 2011 | ||||
| 15.09. | Court Rules in Favor of Fenwal in Nearly 6-Year U.S. Patent Dispute with Haemonetics | 32 | Business Wire | |
| The United States District Court for the District of Massachusetts has
granted Fenwal's motions for summary judgment in two related patent
lawsuits brought by Haemonetics... Mehr lesen zu: Court Rules in Favor of Fenwal in Nearly 6-Year U.S. Patent Dispute with Haemonetics | ||||
| 12.09. | Haemonetics Achieves Time Savings and Business Process Efficiencies with Accounts Receivable Automation from Esker | 12 | Business Wire | |
| Esker, the leader in document process automation solutions today
announced that it has been selected by medical device manufacturer
Haemonetics, the global leader in blood... Mehr lesen zu: Haemonetics Achieves Time Savings and Business Process Efficiencies with Accounts Receivable Automation from Esker | ||||
| 06.09. | Haemonetics to Present at UBS Global Lifesciences Conference | 24 | PR Newswire | |
| BRAINTREE, Mass., Sept. 6, 2011 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced today that Christopher Lindop, CFO & VP, Business Development, will present at the UBS Global Lifesciences... Mehr lesen zu: Haemonetics to Present at UBS Global Lifesciences Conference | ||||
| 30.08. | Gerry Gould Joins Haemonetics as Vice President, Investor Relations | 58 | PR Newswire | |
| BRAINTREE, Mass., Aug. 29, 2011 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Gerry Gould has joined Haemonetics effective today as Vice President, Investor Relations, reporting... Mehr lesen zu: Gerry Gould Joins Haemonetics as Vice President, Investor Relations | ||||
Startseite • Nachrichten • Aktienkurse • Xetra-Orderbuch • Watchlist
Ad hoc-Mitteilungen • Chartanalysen • Nachrichten Börsen • Aktien-Empfehlungen
Branchen • Medien • Nachrichten-Archiv
Impressum | AGB | Disclaimer • Presse • Mediadaten
RSS-News von FinanzNachrichten.de kostenlos für Ihren Browser und Ihre Homepage
